ImCare Biotech

About:

ImCare Biotech is a provider of quality diagnostic and pharmaceutical products for the treatment of cancers.

Website: http://www.imcarebiotech.com

Description:

ImCare Biotech is a biotechnology company that provides diagnostic and pharmaceutical products intended to use for the treatment of cancers, viral infections, and other long-term illnesses. The company’s primary products in development are innovative diagnostic biomarkers as well as developmental drugs for the treatment of liver diseases such as hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). It aims to improve the standard of care for patients and their loved ones. With research and innovation as the heart of the company, it hopes to use deliver high-quality commercial products through smart and focused product development. ImCare Biotech was founded in 2011 and is headquartered in Doylestown, Pennsylvania.

Total Funding Amount:

$2.48M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Doylestown, Pennsylvania, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)imcarebiotech.com

Founders:

Xuanyong Lu

Number of Employees:

1-10

Last Funding Date:

2023-07-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai